US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

F/m Emerald Life Sciences Innovation ETF

48.06

+0.57331.21%

Post-market: 47.11-0.9528-1.98%19:30 EDT

Volume:5K

Turnover:221.35K

Market Cap:132.51M

PE:- -

High:48.19

Open:48.00

Low:47.87

Close:47.49

52wk High:48.78

52wk Low:27.34

Shares:2.76M

Float Shares:2.76M

Volume Ratio:1.31

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Guardant Health Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Guardant Health Inc : RBC Raises Target Price to $200 from $185

THOMSON REUTERS

Guardant Health files automatic mixed securities shelf

Guardant Health Inc Files for Mixed Shelf Offering; Size not Disclosed- SEC Filing

THOMSON REUTERS

Guardant Health Q2 Adjusted Loss Narrows, Revenue Rises

MT Newswires Live

Guardant Health Q2 Adj. EPS $(0.42) Misses $(0.41) Estimate, Sales $334.978M Beat $314.226M Estimate

Benzinga Earnings

Guardant Health Q2 Adjusted EPS USD -0.42 Vs. IBES Estimate USD -0.41

Guardant Health - Sees 2026 Free Cash Flow Burn $195-$205 Mln

THOMSON REUTERS

Guardant Health to Present at Canaccord Genuity Growth Conference Fireside Chat

Viatris receives FDA approval for Gwyn Lo contraceptive patch

Travere Therapeutics to Report Q2 Financial Results After US Market Close

Freenome, Abbott announce FDA approval of SimpleScreen CRC

Pacira transitions PCRX-201 to a U.S.-based manufacturing process

Patrys flags investment risks and uncertainty around therapeutic drug development

Spyre Therapeutics (SYRE) Receives a Buy from Guggenheim

Travere Therapeutics (TVTX) Gets a Buy from Guggenheim

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), McKesson (MCK) and TG Therapeutics (TGTX)

AFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.

Exploring High Growth Tech Stocks In The US For July 2026

Simply Wall St.

Amneal receives FDA approval for additional iohexol strengths, presentations

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/LFSC/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LFSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","market":"US","secType":"STK","nameCN":"F/m Emerald Life Sciences Innovation ETF","latestPrice":48.0628,"timestamp":1787688000000,"preClose":47.4895,"halted":0,"volume":4612,"hourTrading":{"tag":"盘后","latestPrice":47.11,"preClose":48.0628,"latestTime":"19:30 EDT","volume":194,"amount":9205.2812,"timestamp":1787700602165,"change":-0.9528,"changeRate":-0.019824,"amplitude":0.019142},"delay":0,"changeRate":0.012072142263026633,"floatShares":2757035,"shares":2757035,"eps":0,"marketStatus":"Closed","change":0.5733,"latestTime":"08-25 16:00:00 EDT","open":48,"high":48.19,"low":47.87,"amount":221346.80604,"amplitude":0.006738,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":47.4895,"sharesOutstanding":2657035,"nav":47.45,"aum":130821310.75,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":47.11,"preClose":48.0628,"latestTime":"19:30 EDT","volume":194,"amount":9205.2812,"timestamp":1787700602165,"change":-0.9528,"changeRate":-0.019824,"amplitude":0.019142},"volumeRatio":1.311494},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","floatShares":2757035,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.311494,"shares":2757035,"dividePrice":0,"high":48.19,"amplitude":0.006738,"preClose":47.4895,"low":47.87,"week52Low":27.3402,"pbRate":"--","week52High":48.78,"institutionHeld":0,"latestPrice":48.0628,"eps":0,"divideRate":0,"volume":4612,"delay":0,"ttmEps":0,"open":48,"prevYearClose":36.6147,"prevWeekClose":47.7953,"prevMonthClose":45.55,"prevQuarterClose":45.2033,"fiveDayClose":47.489,"twentyDayClose":45.3952,"sixtyDayClose":39.3901},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LFSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LFSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LFSC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LFSC\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655353488","title":"Guardant Health Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2655353488","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655353488?lang=en_us&edition=fundamental","pubTime":"2026-07-31 15:36","pubTimestamp":1785483375,"startTime":"0","endTime":"0","summary":"Guardant Health Inc reports results for the quarter ended June 30 - Earnings SummaryGuardant Health IncGH.OQreported a quarterly adjusted loss of 42 cents per share for the quarter ended June 30, high","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL8N43X0PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4535","GDOC","BK4588","FFOX","GH","GNMX","LFSC","LU0109394709.USD","EKG","BK4585","BK4551","GNOM","PTH","BK4196","LU0889565916.HKD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655330669","title":"Guardant Health Inc : RBC Raises Target Price to $200 from $185","url":"https://stock-news.laohu8.com/highlight/detail?id=2655330669","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655330669?lang=en_us&edition=fundamental","pubTime":"2026-07-31 14:39","pubTimestamp":1785479966,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X1FY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","LU0109394709.USD","LU0889565916.HKD","GDOC","HELX","BK4551","BK4585","BK4196","GNOM","LU0320765992.SGD","FFOX","EKG","GH","BK4588","LFSC","PTH","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655381477","title":"Guardant Health files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2655381477","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655381477?lang=en_us&edition=fundamental","pubTime":"2026-07-31 05:35","pubTimestamp":1785447326,"startTime":"0","endTime":"0","summary":"17:32 EDT Guardant Health (GH) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","FFOX","BK4588","LFSC","PTH","GH","LU0320765992.SGD","EKG","GDOC","BK4551","HELX","LU0109394709.USD","GNOM","BK4535","LU0889565916.HKD","GNMX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655838199","title":"Guardant Health Inc Files for Mixed Shelf Offering; Size not Disclosed- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2655838199","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655838199?lang=en_us&edition=fundamental","pubTime":"2026-07-31 05:31","pubTimestamp":1785447087,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nFWN43W2KQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LFSC","GH","BK4588","HELX","LU0889565916.HKD","GNOM","LU0109394709.USD","BK4535","EKG","GNMX","FFOX","BK4196","LU0320765992.SGD","GDOC","PTH","BK4585","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655386195","title":"Guardant Health Q2 Adjusted Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2655386195","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655386195?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:25","pubTimestamp":1785443116,"startTime":"0","endTime":"0","summary":"Guardant Health  reported Thursday Q2 adjusted loss of $0.42 per diluted share, compared with a loss of $0.44 a year earlier.Analysts polled by FactSet expected loss of $0.39.Revenue for the quarter ended June 30 was $335.0 million, up from $232.1 million a year ago.Analysts expected $314.2 million.The company now expects full year 2026 revenue between $1.34 billion and $1.36 billion, up from $1.30 billion to $1.32 billion earlier. Analysts expect $1.31 billion.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GH","LFSC","BK4588","EKG","FFOX","LU0320765992.SGD","GNOM","BK4585","HELX","BK4551","BK4535","GDOC","PTH","BK4196","LU0109394709.USD","LU0889565916.HKD","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655438321","title":"Guardant Health Q2 Adj. EPS $(0.42) Misses $(0.41) Estimate, Sales $334.978M Beat $314.226M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2655438321","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655438321?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:06","pubTimestamp":1785441998,"startTime":"0","endTime":"0","summary":"Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.41) by 2.44 percent. This is a 4.55 percent increase over losses of $(0.44) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60820598/guardant-health-q2-adj-eps-0-42-misses-0-41-estimate-sales-334-978m-beat-314-226m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Q2 Adj. EPS $(0.42) Misses $(0.41) Estimate, Sales $334.978M Beat $314.226M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4585","LU0320765992.SGD","BK4535","FFOX","LU0889565916.HKD","BK4551","GDOC","HELX","GNMX","LFSC","BK4588","GH","GNOM","PTH","BK4196","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655383221","title":"Guardant Health Q2 Adjusted EPS USD -0.42 Vs. IBES Estimate USD -0.41","url":"https://stock-news.laohu8.com/highlight/detail?id=2655383221","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655383221?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:06","pubTimestamp":1785441961,"startTime":"0","endTime":"0","summary":"BRIEF-Guardant Health Q2 Adjusted EPS USD -0.42 Vs. IBES Estimate USD -0.41Jul 30  - Guardant Health Q2 revenue USD 335 million vs. IBES estimate USD 314.2 million.Q2 EPS USD -0.9Q2 adjusted net income USD -56.2 million vs. IBES estimate USD -54.3 millionQ2 adjusted EBITDA USD -55.9 million vs. IBES estimate USD -50.3 millionoutlook FY revenue USD 1,340-1,360 million vs. IBES estimate USD 1,314 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nPLXKDV64K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","LU0320765992.SGD","LU0889565916.HKD","BK4535","BK4585","BK4588","GNMX","LFSC","LU0109394709.USD","GDOC","GH","PTH","GNOM","BK4196","HELX","EKG","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655538687","title":"Guardant Health - Sees 2026 Free Cash Flow Burn $195-$205 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2655538687","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655538687?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:05","pubTimestamp":1785441902,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nPLXKDV64K:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LFSC","GH","BK4588","HELX","LU0889565916.HKD","GNOM","LU0109394709.USD","BK4535","EKG","GNMX","FFOX","BK4196","LU0320765992.SGD","GDOC","PTH","BK4585","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655816518","title":"Guardant Health to Present at Canaccord Genuity Growth Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2655816518","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655816518?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:09","pubTimestamp":1785355797,"startTime":"0","endTime":"0","summary":"Guardant Health to present at Canaccord Genuity growth conference fireside chatGuardant Health will join the Canaccord Genuity 46th Annual Growth Conference on Aug. 12, featuring a 3:00 p.m. ET firesi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL69rpsx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0971096721.USD","HELX","BK4534","FFOX","LU1244550577.SGD","LU0314104364.USD","BK4581","LU2271345857.HKD","LU1791710400.SGD","LU0006306889.USD","LU0053666078.USD","LU1162221912.USD","LU1074936037.SGD","BK4588","LU1668664300.SGD","LU1720051017.SGD","PTH","LU1732800096.USD","LU0098860793.USD","IE00BZ1G4Q59.USD","GH","LFSC","KBWB","LU0795875169.SGD","LU1720051108.HKD","LU0109394709.USD","LU0225283273.USD","LU0320765646.SGD","LU1244550221.USD","LU2023251221.USD","GDOC","LU2264538146.SGD","BK4585","BK4551","LU2089283258.USD","LU2089284900.SGD","LU0889565916.HKD","GNOM","IAI","BK4516","LU0557290698.USD","LU0267386448.USD","LU1548497426.USD","EKG","GNMX","LU1989772840.SGD","LU0912757837.SGD","BK4504","LU0210528500.USD","LU0158827781.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655895830","title":"Viatris receives FDA approval for Gwyn Lo contraceptive patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2655895830","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655895830?lang=en_us&edition=fundamental","pubTime":"2026-07-29 21:16","pubTimestamp":1785330964,"startTime":"0","endTime":"0","summary":"Viatris (VTRS) announced that the FDA has approved Gwyn Lo, a new combined hormonal contraceptive patch with low-dose estrogen. The patch has demon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viatris-receives-fda-approval-for-gwyn-lo-contraceptive-patch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viatris-receives-fda-approval-for-gwyn-lo-contraceptive-patch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","IYH","TECB","BBP","VTRS","FRTY","IBB","IDNA","XLVX","BMED","LU1839511570.USD","PSCH","GDOC","TBXU","BK4583","BK4585","RSPH","SYNB","GNMX","LU2087621335.USD","LFSC","IEIH","BK4588","MRNY","MRNX","MEDI","PINK","BK4007","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655388028","title":"Travere Therapeutics to Report Q2 Financial Results After US Market Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2655388028","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655388028?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:30","pubTimestamp":1785270657,"startTime":"0","endTime":"0","summary":"Travere Therapeutics to report Q2 financial results after US market closeTravere Therapeutics schedules Q2 2026 results for Aug. 4, 2026, released after the U.S. market close.Conference call, webcast ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDLcdq5CB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LFSC","TVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654010379","title":"Freenome, Abbott announce FDA approval of SimpleScreen CRC","url":"https://stock-news.laohu8.com/highlight/detail?id=2654010379","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654010379?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:16","pubTimestamp":1785154580,"startTime":"0","endTime":"0","summary":"Freenome (FRNM) and Abbott (ABT) announced that the FDA has approved SimpleScreen CRC, a new blood-based screening option for colorectal cancer in ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/freenome-abbott-announce-fda-approval-of-simplescreen-crc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/freenome-abbott-announce-fda-approval-of-simplescreen-crc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1691799644.USD","LFSC","LU2468319806.SGD","PINK","BK4504","IYH","LU1914381329.SGD","LABU","RSPH","IDNA","PSCH","BK4082","LU1721429741.USD","IHI","GDOC","IE0002141913.USD","LU2133065610.SGD","TBXU","XLVX","LU1061106388.HKD","NVIB","LU0266512127.USD","TMED","MEDI","BK4585","SG9999002232.USD","SGXZ41872573.SGD","SYNB","TECB","MRNX","SG9999002224.SGD","FRTY","ABT","PJP","LU0170899867.USD","LU2324357040.USD","LU0266013472.USD","IEIH","BBP","GNMX","CRC","BK4588","IBB","BK4213","LU1721429402.USD","LU2112291526.USD","BMED","MRNY","FRNM","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654010362","title":"Pacira transitions PCRX-201 to a U.S.-based manufacturing process","url":"https://stock-news.laohu8.com/highlight/detail?id=2654010362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654010362?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:10","pubTimestamp":1785154247,"startTime":"0","endTime":"0","summary":"Pacira (PCRX) announced that it has successfully transitioned PCRX-201, its investigational locally administered gene therapy for osteoarthritis of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pacira-transitions-pcrx-201-to-a-u-s-based-manufacturing-process-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pacira-transitions-pcrx-201-to-a-u-s-based-manufacturing-process-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","BK4588","EES","FBT","CNCR","IBBQ","BK4585","TBXU","IBB","SYNB","PCRX","BK4007","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654672100","title":"Patrys flags investment risks and uncertainty around therapeutic drug development","url":"https://stock-news.laohu8.com/highlight/detail?id=2654672100","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654672100?lang=en_us&edition=fundamental","pubTime":"2026-07-27 06:51","pubTimestamp":1785106305,"startTime":"0","endTime":"0","summary":"Patrys Limited ( ($AU:PAB) ) has provided an update. Patrys Limited has released a general information presentation outlining its activities in res...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/patrys-flags-investment-risks-and-uncertainty-around-therapeutic-drug-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/patrys-flags-investment-risks-and-uncertainty-around-therapeutic-drug-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PAB","BMED","FBT","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654105391","title":"Spyre Therapeutics (SYRE) Receives a Buy from Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2654105391","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654105391?lang=en_us&edition=fundamental","pubTime":"2026-07-25 09:25","pubTimestamp":1784942732,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Yatin Suneja from Guggenheim reiterated a Buy rating on Spyre Therapeutics, with a price target of $115.00. Suneja ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/spyre-therapeutics-syre-receives-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/spyre-therapeutics-syre-receives-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LFSC","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653789947","title":"Travere Therapeutics (TVTX) Gets a Buy from Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2653789947","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653789947?lang=en_us&edition=fundamental","pubTime":"2026-07-22 06:26","pubTimestamp":1784672788,"startTime":"0","endTime":"0","summary":"In a report released today, Vamil Divan from Guggenheim reiterated a Buy rating on Travere Therapeutics, with a price target of $65.00. Divan cover...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/travere-therapeutics-tvtx-gets-a-buy-from-guggenheim-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/travere-therapeutics-tvtx-gets-a-buy-from-guggenheim-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FFTY","TVTX","BK4139","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653005872","title":"Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), McKesson (MCK) and TG Therapeutics (TGTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2653005872","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653005872?lang=en_us&edition=fundamental","pubTime":"2026-07-22 03:01","pubTimestamp":1784660496,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Travere Therapeutics (TVTX), McKesson (MCK) and TG T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-mckesson-mck-and-tg-therapeutics-tgtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-mckesson-mck-and-tg-therapeutics-tgtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0203345920.USD","LU2112291526.USD","LU1023059063.AUD","TGTX","LU2324357040.USD","LFSC","LU0314106906.USD","LU0742534661.SGD","XBI","LU1037948541.HKD","BK4588","LU1585245621.USD","LU0882574055.USD","LU1983260115.SGD","LU0048573561.USD","LU0203347892.USD","LU0942090050.USD","LU1366192091.USD","LU0965509010.AUD","LU1506573853.SGD","LU0689626769.HKD","LU0124676726.USD","BK4175","LU2468319806.SGD","LU1037948897.HKD","LABU","LU0029874061.USD","LU0965509283.SGD","LU1934455277.USD","TG","LU0114720955.EUR","LU0965508806.USD","MCK","BK4139","FFTY","TVTX","LU0868494708.USD","LU1057294990.SGD","LU1061106388.HKD","LU1430594728.SGD","LU0128526141.USD","HCSG","LU0868494617.USD","BK4090","LU1934455863.HKD","BK4533","XLV","LU0432979614.USD","BK4581","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653529241","title":"AFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2653529241","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653529241?lang=en_us&edition=fundamental","pubTime":"2026-07-21 06:47","pubTimestamp":1784587635,"startTime":"0","endTime":"0","summary":"An announcement from AFT Pharmaceuticals Ltd. ( ($NZ:AFT) ) is now available. AFT Pharmaceuticals has received tentative U.S. FDA approval for Scom...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aft-pharmaceuticals-secures-tentative-fda-nod-for-scomara-eyes-growth-outside-u-s?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aft-pharmaceuticals-secures-tentative-fda-nod-for-scomara-eyes-growth-outside-u-s?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","MRNY","BMED","AFT","IBB","BBP","GDOC","FRTY","LABU","MEDI","PINK","SYNB","RSPH","PSCH","MRNX","IDNA","LFSC","TECB","IYH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652213621","title":"Exploring High Growth Tech Stocks In The US For July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2652213621","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652213621?lang=en_us&edition=fundamental","pubTime":"2026-07-20 19:08","pubTimestamp":1784545699,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has experienced a slight decline of 1.4%, yet it remains robust with a 17% increase over the past year and earnings projected to grow by 18% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and resilience in fluctuating market conditions.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8042000-choice2-main-header/1585186807378","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8042000-choice2-main-header/1585186807378"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nyse-net/cloudflare/news/exploring-high-growth-tech-stocks-in-the-us-for-july-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nyse-net/cloudflare/news/exploring-high-growth-tech-stocks-in-the-us-for-july-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MDGL","BK4560","TVTX","BK4585","BK4548","LU2065171402.SGD","BK4116","NET","LU2065170008.USD","NETG","LU2065169927.USD","BK4607","BK4613","BK4554","NETX","CLOU","FFTY","BK4588","LU2286300806.USD","BK4139","LFSC","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652882192","title":"Amneal receives FDA approval for additional iohexol strengths, presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2652882192","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652882192?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:15","pubTimestamp":1784290509,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals (AMRX) announced that it has received FDA approval for additional strengths and vial presentations of iohexol injection, 350...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amneal-receives-fda-approval-for-additional-iohexol-strengths-presentations-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amneal-receives-fda-approval-for-additional-iohexol-strengths-presentations-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PINK","BK4585","MEDI","MRNY","MRNX","IDNA","BBP","PSCH","LFSC","BK4007","BMED","RSPH","TECB","SYNB","GDOC","IBB","IYH","FRTY","LABU","BK4588","AMRX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":198,"code":"91000000","status":"200"}]}}